vs
AdvanSix Inc.（ASIX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是AdvanSix Inc.的2.0倍（$711.1M vs $359.9M），Revvity净利率更高（5.7% vs -0.8%，领先6.5%），Revvity同比增速更快（13.1% vs 9.4%），过去两年AdvanSix Inc.的营收复合增速更高（3.4% vs 1.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
ASIX vs RVTY — 直观对比
营收规模更大
RVTY
是对方的2.0倍
$359.9M
营收增速更快
RVTY
高出3.7%
9.4%
净利率更高
RVTY
高出6.5%
-0.8%
两年增速更快
ASIX
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $711.1M |
| 净利润 | $-2.8M | $40.7M |
| 毛利率 | 7.6% | 54.5% |
| 营业利润率 | -0.7% | — |
| 净利率 | -0.8% | 5.7% |
| 营收同比 | 9.4% | 13.1% |
| 净利润同比 | -892.9% | 361.2% |
| 每股收益（稀释后） | $-0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXRVTY
| Q1 26 | — | $711.1M | ||
| Q4 25 | $359.9M | $772.1M | ||
| Q3 25 | $374.5M | $698.9M | ||
| Q2 25 | $410.0M | $720.3M | ||
| Q1 25 | $377.8M | $664.8M | ||
| Q4 24 | $329.1M | $729.4M | ||
| Q3 24 | $398.2M | $684.0M | ||
| Q2 24 | $453.5M | $691.7M |
净利润ASIXRVTY
| Q1 26 | — | $40.7M | ||
| Q4 25 | $-2.8M | $98.4M | ||
| Q3 25 | $-2.6M | $46.7M | ||
| Q2 25 | $31.4M | $53.9M | ||
| Q1 25 | $23.3M | $42.2M | ||
| Q4 24 | $352.0K | $94.6M | ||
| Q3 24 | $22.3M | $94.4M | ||
| Q2 24 | $38.9M | $55.4M |
毛利率ASIXRVTY
| Q1 26 | — | 54.5% | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | 53.6% | ||
| Q2 25 | 14.3% | 54.5% | ||
| Q1 25 | 14.2% | 56.5% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | 56.3% | ||
| Q2 24 | 17.9% | 55.7% |
营业利润率ASIXRVTY
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | 14.5% | ||
| Q3 25 | -0.9% | 11.7% | ||
| Q2 25 | 7.7% | 12.6% | ||
| Q1 25 | 7.7% | 10.9% | ||
| Q4 24 | -3.9% | 16.3% | ||
| Q3 24 | 7.5% | 14.3% | ||
| Q2 24 | 11.5% | 12.4% |
净利率ASIXRVTY
| Q1 26 | — | 5.7% | ||
| Q4 25 | -0.8% | 12.7% | ||
| Q3 25 | -0.7% | 6.7% | ||
| Q2 25 | 7.7% | 7.5% | ||
| Q1 25 | 6.2% | 6.4% | ||
| Q4 24 | 0.1% | 13.0% | ||
| Q3 24 | 5.6% | 13.8% | ||
| Q2 24 | 8.6% | 8.0% |
每股收益（稀释后）ASIXRVTY
| Q1 26 | — | — | ||
| Q4 25 | $-0.11 | $0.86 | ||
| Q3 25 | $-0.10 | $0.40 | ||
| Q2 25 | $1.15 | $0.46 | ||
| Q1 25 | $0.86 | $0.35 | ||
| Q4 24 | $0.02 | $0.77 | ||
| Q3 24 | $0.82 | $0.77 | ||
| Q2 24 | $1.43 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $860.3M |
| 总债务越低越好 | — | $3.2B |
| 股东权益账面价值 | $815.2M | $7.2B |
| 总资产 | $1.7B | $12.0B |
| 负债/权益比越低杠杆越低 | — | 0.45× |
8季度趋势，按日历期对齐
现金及短期投资ASIXRVTY
| Q1 26 | — | $860.3M | ||
| Q4 25 | $19.8M | $919.9M | ||
| Q3 25 | $23.7M | $931.4M | ||
| Q2 25 | $18.4M | $991.8M | ||
| Q1 25 | $8.3M | $1.1B | ||
| Q4 24 | $19.6M | $1.2B | ||
| Q3 24 | $17.3M | $1.2B | ||
| Q2 24 | $12.1M | $2.0B |
总债务ASIXRVTY
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASIXRVTY
| Q1 26 | — | $7.2B | ||
| Q4 25 | $815.2M | $7.3B | ||
| Q3 25 | $818.2M | $7.4B | ||
| Q2 25 | $823.7M | $7.6B | ||
| Q1 25 | $794.4M | $7.6B | ||
| Q4 24 | $774.6M | $7.7B | ||
| Q3 24 | $766.4M | $7.9B | ||
| Q2 24 | $746.6M | $7.9B |
总资产ASIXRVTY
| Q1 26 | — | $12.0B | ||
| Q4 25 | $1.7B | $12.2B | ||
| Q3 25 | $1.7B | $12.1B | ||
| Q2 25 | $1.6B | $12.4B | ||
| Q1 25 | $1.6B | $12.4B | ||
| Q4 24 | $1.6B | $12.4B | ||
| Q3 24 | $1.5B | $12.8B | ||
| Q2 24 | $1.5B | $13.4B |
负债/权益比ASIXRVTY
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $125.9M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | 2.8% |
| 现金转化率经营现金流/净利润 | — | 3.09× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
经营现金流ASIXRVTY
| Q1 26 | — | $125.9M | ||
| Q4 25 | $63.7M | $182.0M | ||
| Q3 25 | $26.6M | $138.5M | ||
| Q2 25 | $21.1M | $134.3M | ||
| Q1 25 | $11.4M | $128.2M | ||
| Q4 24 | $64.2M | $174.2M | ||
| Q3 24 | $57.3M | $147.9M | ||
| Q2 24 | $50.2M | $158.6M |
自由现金流ASIXRVTY
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | $161.8M | ||
| Q3 25 | $66.0K | $120.0M | ||
| Q2 25 | $-7.2M | $115.5M | ||
| Q1 25 | $-22.6M | $112.2M | ||
| Q4 24 | $29.8M | $149.8M | ||
| Q3 24 | $26.8M | $125.6M | ||
| Q2 24 | $16.7M | $136.6M |
自由现金流率ASIXRVTY
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 21.0% | ||
| Q3 25 | 0.0% | 17.2% | ||
| Q2 25 | -1.7% | 16.0% | ||
| Q1 25 | -6.0% | 16.9% | ||
| Q4 24 | 9.1% | 20.5% | ||
| Q3 24 | 6.7% | 18.4% | ||
| Q2 24 | 3.7% | 19.7% |
资本支出强度ASIXRVTY
| Q1 26 | — | 2.8% | ||
| Q4 25 | 7.7% | 2.6% | ||
| Q3 25 | 7.1% | 2.6% | ||
| Q2 25 | 6.9% | 2.6% | ||
| Q1 25 | 9.0% | 2.4% | ||
| Q4 24 | 10.4% | 3.4% | ||
| Q3 24 | 7.7% | 3.3% | ||
| Q2 24 | 7.4% | 3.2% |
现金转化率ASIXRVTY
| Q1 26 | — | 3.09× | ||
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 0.67× | 2.49× | ||
| Q1 25 | 0.49× | 3.03× | ||
| Q4 24 | 182.29× | 1.84× | ||
| Q3 24 | 2.57× | 1.57× | ||
| Q2 24 | 1.29× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
RVTY
暂无分部数据
